Neonatal lupus erythematosus: A review of the racial differences and similarities in clinical, serological and immunogenetic features of Japanese versus Caucasian patients

Journal of Dermatology

Volumn 32, Issue 7, 2005, Pages 514-522

  Miyagawa, Sachiko ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Congenital heart block; Neonatal lupus erythematosus; Ro SSA, La SSB

Indexed keywords

HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; HLA DR3 ANTIGEN; MATERNAL ANTIBODY; RO ANTIBODY;

ASIAN; CAUCASIAN; CLINICAL FEATURE; CONGENITAL HEART BLOCK; EDEMA; ERYTHEMA; HUMAN; IMMUNOGENETICS; JAPAN; JAPANESE; LEUKOCYTOCLASTIC VASCULITIS; MATERNAL DISEASE; NEWBORN DISEASE; NEWBORN LUPUS ERYTHEMATOSUS; PHOTOSENSITIVITY; RACE DIFFERENCE; REVIEW; SJOEGREN SYNDROME; SKIN LUPUS ERYTHEMATOSUS; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 23944482088     PISSN: 03852407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2005.tb00793.x     Document Type: Review

References (72)

1. McCuistion CH, Schoch EP: Possible discoid lupus erythematosus in newborn infant. Report of a case with subsequent development of acute systemic lupus erythematosus in mother, Arch Dermatol, 70: 782-785, 1954.
2. Scott JS, Maddison PJ, Taylor PV, Esscher E, Scott O, Skinner RP: Connective tissue disease, antibodies to ribonucleoprotein and congenital heart block, N Engl J Med, 309: 209-212, 1983.
3. Reed BR, Lee LA, Harmon C, et al: Autoantibodies to SS-A/Ro in infants with congenital heart block, J Pediatr, 103: 889-891, 1983.
4. Watson RM, Lane AT, Barnett NK, Bias WB, Arnett FC, Provost TT: Neonatal lupus erythematosus. A clinical, serological and immunogenetic study with review of the literature, Medicine, 63: 362-378, 1984.
5. McCune AB, Weston WL, Lee LA: Maternal and fetal outcome in neonatal lupus erythematosus, Ann Intern Med, 106: 518-523, 1987.
6. Silverman ED, Laxer RM: Neonatal lupus erythematosus, Rheum Dis Clin North Am, 23: 599-618, 1997.
7. Franco HL, Weston WL, Peebles C, Forstot SL, Phanuphak P: Autoantibodies directed against sicca syndrome antigens in the neonatal lupus syndrome, J Am Acad Dermatol, 4: 67-72, 1981.
8. Miyagawa S, Kitamura W, Yoshioka J, Sakamoto K: Placental transfer of anticytoplasmic antibodies in annular erythema of newborns, Arch Dermatol, 117: 569-572, 1981.
9. Kephart DC, Hood AF, Provost TT: Neonatal lupus erythematosus: New serologic findings, J Invest Dermatol, 77: 331-333, 1981.
10. Silverman E, Mamula M, Hardin JA, Laxer R: Importance of the immune response to the Ro/La particle in the development of congenital heart block and neonatal lupus erythematosus, J Rheumatol, 18: 120-124, 1991.
11. Lee LA: Neonatal lupus erythematosus, J Invest Dermatol, 100 (suppl): 9S-13S, 1993.
12. Provost TT, Watson RM: Anti-Ro (SS-A) HLA-DR3 positive females: The interrelationship between some ANA negative, SS, SCLE, NLE mothers and SS/LE overlap female patients, J Invest Dermatol, 100 (suppl): 14S-20S, 1993.
13. Brucato A, Franceschini F, Gasparini M, et al: Isolated congenital heart block: Longterm outcome of mothers, maternal antibody specificity and immunogenetic background, J Rheumatol, 22: 533-540, 1995.
14. Sontheimer RD, Thomas JR, Gilliam JN: Subacute cutaneous lupus erythemtosus-A cutaneous marker for a distinct lupus erythematosus subset, Arch Dermatol, 115: 1409-1415, 1979.
15. Neiman AR, Lee LA, Weston WL, Buyon JP: Cutaneous manifestations of neonatal lupus without heart block: Characteristics of mothers and children enrolled in a national registry, J Pediatr, 137: 674-680, 2000.
16. Teramoto N, Katayama I, Arai H, et al: Annular erythema: A possible association with primary Sjögren's syndrome, J Am Acad Dermatol, 20: 596-601, 1989.
17. Miyagawa S, Kitamura W, Sakamoto K: Skin lesions associated with Sjögren's syndrome and anticytoplasmic antibodies in SLE patients, J Dermatol, 10: 495-500, 1983.
18. Nishikawa T, Provost TT: Differences in clinical, serologic, and immunogenetic features of white versus Oriental anti-Ro/SS-A positive patients, J Am Acad Dermatol, 25: 563-564, 1991.
19. Ruzicka T, Faes J, Bergner T, Peter RU, Braun-Falco O: Annular erythema associated with Sjögren's syndrome: A variant of systemic lupus erythematosus, J Am Acad Dermatol, 25: 557-560, 1991.
20. Miyagawa S, Dohi K, Shima H, Shirai T: HLA antigens in anti-Ro (SS-A)-positive patients with recurrent annular erythema, J Am Acad Dermatol, 28: 185-188, 1993.
21. Watanabe T, Tsuchida T, Ito Y, Kanda N, Ueda Y, Tamaki K: Annular erythema associated with lupus erythematosus/Sjögren's syndrome, J Am Acad Dermatol, 36: 214-218, 1997.
22. Miyagawa S, Shinohara K, Nakajima M, et al: Polymorphisms of HLA class II genes and autoimmune responses to Ro/SSA-La/SSB among Japanese subjects, Arthritis Rheum, 41: 927-934, 1998.
23. Kaneko F, Tanji O, Hasegawa T, Ohto H, Yama zaki K: Neonatal lupus erythematosus in Japan, J Am Acad Dermatol, 26: 397-403, 1992.
24. Weston WL, Morelli JG, Lee LA: The clinical spectrum of anti-Ro-positive cutaneous neonatal lupus erythematosus, J Am Acad Dermatol, 40: 675-681, 1999.
25. Nitta Y: Lupus erythematosus profundus associated with neonatal lupus erythematosus, Br J Dermatol, 136: 112-114, 1997.
26. Buyon JP, Hiebert R, Copel J, et al: Autoimmune-associated congenital heart block: Demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry, J Am Coll Cardiol, 31: 1658-1666, 1998.
27. Shinohara K, Miyagawa S, Fujita T, Aono T, Kidoguchi K: Neonatal lupus erythematosus: Results of maternal corticosteroid therapy, Obstet Gynecol, 93: 952-957, 1999.
28. Buyon JP, Ben Chetrit E, Karp S, et al: Acquired congenital heart block. Pattern of maternal antibody response to biochemically defined antigens of the SSA/Ro-SSB/La system in neonatal lupus, J Clin Invest, 84: 627-634, 1989.
29. Buyon JP, Winchester RJ, Slade SG, et al: Identification of mothers at risk for congenital heart block and other neonatal lupus syndromes in their children. Comparison of enzyme-linked immunosorbent assay and immunoblot for measurement of anti-SS-A/Ro and anti-SS-B/La antibodies, Arthritis Rheum, 36: 1263-1273, 1993.
30. Miyagawa S, Shinohara K, Kidoguchi K, et al: Neonatal lupus erythematosus: Studies on HLA class II genes and autoantibody profiles in Japanese mothers, Autoimmunity, 26: 95-101, 1997.
31. Julkunen H, Kurki P, Kaaja R, et al: Isolated congenital heart block: Long-term outcome of mothers and characterization of the immune response to SS-A/Ro and to SS-B/La, Arthritis Rheum, 36: 1588-1598, 1993.
32. Colombo G, Brucato A, Coluccio E, et al: DNA typing of maternal HLA in congenital complete heart block: Comparison with systemic lupus erythematosus and primary Sjögren's syndrome, Arthritis Rheum, 42: 1757-1764, 1999.
33. Harley JB, Kaine JL, Fox OF, Reichlin M, Gruber B: Ro (SS-A) antibody and antigen in a patient with complete congenital heart block, Arthritis Rheum, 28: 1321-1325, 1985.
34. Watson RM, Scheel JN, Petri M, et al: Neonatal lupus erythematosus. Report of serologic and immunogenetic studies in twins discordant for congenital heart block, Br J Dermatol, 130: 342-348, 1994.
35. Waltuck J, Buyon JP: Autoantibody-associated congenital heart block: Outcome in mothers and children, Ann Intern Med, 120: 544-551, 1994.
36. Provost TT, Watson R, Gammon WR, Radowsky M, Harley JB, Reichlin M: The neonatal lupus syndrome associated with U1RNP (nRNP) antibodies, N Engl J Med, 316: 1135-1138, 1987.
37. Dugan EM, Tunnessen WW, Honig PJ, Watson RM: U1RNP antibody-positive neonatal lupus. A report of two cases with immunogenetic studies, Arch Dermatol, 128: 1490-1494, 1992.
38. Maddison PJ, Lee L, Reichlin M, et al: Anti-p57: A novel association with neonatal lupus, Clin Exp Immunol, 99: 42-48, 1995.
39. Haneji N, Nakamura T, Takio K, et al: Identification of α-fodrin as a candidate autoantigen in primary Sjögren's syndrome, Science, 276: 604-607, 1997.
40. Miyagawa S, Yanagi K, Yoshioka A, Kidoguchi K, Shirai T, Hayashi Y: Neonatal lupus erythematosus: Maternal IgG antibodies bind to a recombinant NH2-terminal fusion protein encoded by human á-fodrin cDNA, J Invest Dermatol, 111: 1189-1192, 1998.
41. Orth T, Dörner T, Meyer Zum Büschenfelde KH, Mayet WJ: Complete congenital heart block is associated with increased autoantibody titers against calreticulin, Eur J Clin Invest, 26: 205-215, 1996.
42. Aylward RD: Congenital heart block, Br Med J, 1: 943, 1928.
43. Press J, Uziel Y, Laxer RM, Luy L, Hamilton RM, Silverman ED: Long-term outcome of mothers of children with complete congenital heart block, Am J Med, 100: 328-332, 1996.
44. Borrego L, Rodríguez J, Soler E, Jiménez A, Hernández B: Neonatal lupus erythematosus related to maternal leukocytoclastic vasculitis, Pediatr Dermatol, 14: 221-225, 1997.
45. Senégal J-C, Chartier S, Rothfield N: Hypergammaglobulinemic purpura in systemic autoimmune rheumatic diseases: Predictive value of anti-Ro (SSA) and anti-La (SSB) antibodies and treatment with indomethacin and hydroxychloroquine, J Rheumatol, 22: 868-875, 1995.
46. Miyagawa S, Fukumoto T, Kanauchi M, et al: Hypergammaglobulinaemic purpura of Waldenström and Ro/SSA autoantibodies, Br J Dermatol, 134: 919-923, 1996.
47. Caporali R, Scatola C, Montecucco C: Benign hypergammaglobulinemic purpura and anti-Ro (SSA) antibodies in undifferentiated connective tissue disease, J Rheumatol, 23: 410-411, 1996.
48. Hosokawa K, Tomizawa Y, Kobayashi K, Taka tsuka N: Neonatal lupus erythematosus associated with Sjögren's syndrome in the mother and grandmother, Hifu-Rinsho, 36: 745-748, 1994 (in Japanese).
49. Arakawa H, Ochiai T, Fujitsuka A, Morishima T: Hypergammaglobulinemic purpura occuring in a female delivered of an infant diagnosed with neonatal lupus erythematosus, Nishinihon J Dermatol, 64: 412-415, 2002 (inJapanese).
50. Chameides L, Truex RC, Vetter V, Rashkind WJ, Galioto FM Jr, Noonan JA: Association of maternal systemic lupus erythematosus with congenital complete heart block, N Engl J Med, 297: 1204-1207, 1977.
51. Lee LA, Coulter S, Erner S, Chu H: Cardiac immunoglobulin deposition in congenital heart block associated with maternal anti-Ro autoantibodies, Am J Med, 83: 793-796, 1987.
52. Deng JS, Bair LW Jr, Shen-Schwartz S, Ramsey-Goldman R, Medsger T Jr: Localization of Ro (SS-A) antigen in the cardiac conduction system, Arthritis Rheum, 30: 1232-1238, 1987.
53. Miranda-Carús M-E, Askanase AC, Clancy RM, et al: Anti-SSA/Ro and anti-SSB/La autoantibodies bind the surface of apoptotic fetal cardiocytes and promote secretion of TNF-α by macrophages, J Immunol, 165: 5345-5451, 2000.
54. Buyon JP, Clancy RM: Autoantibody-associated congenital heart block: TGFβ and the road to scar, Autoimmun Rev, 4: 1-7, 2005.
55. Miyagawa S, Shinohara K, Kidoguchi K, et al: Neonatal lupus erythematosus: Haplotypic analysis of HLA class II alleles in child/mother pairs, Arthritis Rheum, 40: 982-983, 1997.
56. Arnett FC Jr: The genetics of human lupus, in Wallace DL, Hahn BH (eds): Dubois' Lupus Erythematosus, 5th ed, Lippincott Williams & Wilkins, Philadelphia, 1997, pp 77-117.
57. Stephens HAF, McHugh NJ, Maddison PJ, Isenberg DA, Welsh KI, Panayi GS: HLA class II restriction of autoantibody production in patients with systemic lupus erythematosus, Immunogenetics, 33: 276-280, 1991.
58. Miyagawa S, Shinohara K, Kidoguchi K, et al: Neonatal lupus erythematosus: HLA-DR and -DQ distributions are different among the groups of anti-Ro/SSA positive mothers with different neonatal outcomes, J Invest Dermatol, 108: 881-885, 1997.
59. Sirén M-K, Julkunen H, Kaaja R, Ekblad H, Koskimies S: Role of HLA in congenital heart block: Susceptibility alleles in children, Lupus, 8: 60-67, 1999.
60. Buyon JP, Swersky SH, Fox HE, Bierman FZ, Winchester RJ: Intrauterine therapy for presumptive fetal myocarditis with acquired heart block due to systemic lupus erythematosus. Experience in a mother with a predominance of SS-B (La) antibodies, Arthritis Rheum, 30: 44-49, 1987.
61. Carreira PE, Gutierrez-Larraya F, Gomez-Reino JJ: Successful intrauterine therapy with dexamethasone for fetal myocarditis and heart block in a woman with systemic lupus erythematosus, J Rheumatol, 20: 1204-1207, 1993.
62. Rider LG, Buyon JP, Rutledge J, Sherry DD: Treatment of neonatal lupus: Case report and review of the literature, J Rheumatol, 20: 1208-1211, 1993.
63. Copel JA, Buyon JP, Kleinman CS: Successful in utero therapy of fetal heart block, Am J Obstet Gynecol, 173: 1384-1390, 1995.
64. Saleeb S, Copel J, Friedman D, Buyon JP: Comparison of treatment with fluorinated glucocorticoids to the natural history of autoantibody-associated congenital heart block, Arthritis Rheum, 42: 2335-2345, 1999.
65. Geggel RL, Tucker L, Szer I: Postnatal progression from second- to third-degree heart block in neonatal lupus syndrome, J Pediatr, 113: 1049-1052, 1988.
66. Ishimaru S, Izaki S, Kitamura K, Morita Y: Neonatal lupus erythematosus: Dissolution of atrioventricular block after administration of corticostroid to the pregnant mother, Dermatology, 189: 92-94, 1994.
67. Bierman FZ, Baxi L, Jaffe I, Driscoll J: Fetal hydrops and congenital complete heart block: Response to maternal steroid therapy, J Pediatr, 112: 646-648, 1988.
68. Watson WJ, Katz VL: Steroid therapy for hydrops associated with antibody-mediated congenital heart block, Am J Obstet Gynecol, 165: 553-554, 1991.
69. James TN: Cardiac conduction system: Fetal and postnatal development, J Cardiogr, 25: 213-225, 1970.
70. Buyon JP, Winchester R: Congenital complete heart block. A human model of passively acquired autoimmune injury, Arthritis Rheum, 33: 609-614, 1990.
71. 7l) Kitridou R: The neonatal lupus syndrome, in Wallace DJ, Hahn BH (eds): Dubois' Lupus Erythematosus, 6th ed, Lippincott Williams & Wilkins, Philadelphia, 2002, pp 1041-1059.
72. Nakajima S, Ishii K, Furukawa S, Morioka S: A case of neonatal lupus erythematosus progressing into systemic lupus erythematosus, Jap J Pediatr Dermatol, 9: 41-45, 1990 (in Japanese).